ZEUS Scientific, Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
ZEUS Scientific, Inc. - overview
Established
1976
Location
-, NJ, US
Primary Industry
Medical Devices & Equipment
About
Based in New Jersey, US, and founded in 1976, ZEUS Scientific, Inc. operates as an In Vitro Diagnostic (IVD) company that designs and manufactures clinical diagnostic solutions. In October 2022, Sebia S. A.
, a global specialty diagnostic company and a portfolio company of CDPQ, CVC Capital Partners, and Tethys Invest, acquired ZEUS Scientific, LLC. As of October 2022, the company is led by its CEO Scott Tourville. ZEUS Scientific, Inc. focuses on the development, production, and marketing of Athena Multi-Lyte® test systems, ZEUS ELISA™ test systems, and ZEUS IFA™ test systems to detect autoimmune and infectious diseases.
Its areas include inflammatory rheumatic diseases, serological detection of autoimmune vasculitis, thyroid diagnostics, gastroenterology, and a number of infectious diseases, with a strong focus on Lyme disease.
Current Investors
Sebia S.A.
Primary Industry
Medical Devices & Equipment
Sub Industries
Diagnostic Equipment, Analytics & Performance Software, Application Integration Software, Medical Software
Website
www.zeusscientific.com
Verticals
HealthTech, Manufacturing
Company Stage
Add-on
Total Amount Raised
Subscriber access only
ZEUS Scientific, Inc. - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Add-on | Completed | ZEUS Scientific, Inc. | - |
Displaying 1 - 1 of 1
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.